MAHABANK NSE filing

Bank of Maharashtra Board Approves Q2 & H1 FY26 Financial Results; Highlights Provisions & Frauds

The RealCase readHigh impact Neutral

Bank of Maharashtra's board approved Q2 and H1 FY26 standalone and consolidated financial results. Noted ₹1200 Crore COVID-19 provision, 100% provision for ₹133.73 Crore fraud loss, and 98.34% PCR.

Why it matters

The announcement contains the bank's financial results for a quarter and half year, which are critical indicators of its performance and financial health, making it highly impactful for investors and stakeholders.

The market read

The announcement is a factual disclosure of financial results and related compliance matters. While fraud provisions and PCR are positive aspects, the procedural note on the audit committee quorum and RBI penalties balance the sentiment to neutral without specific performance figures.

Bank of Maharashtra's Board of Directors met on October 14, 2025, and approved the Unaudited (Reviewed) Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2025. Key highlights include: * The Board approved the financial results, which were reviewed by Statutory Central Auditors with an unmodified opinion. * Due to an insufficient number of Independent Directors, the Bank invoked Para 14A of the Nationalised Banks (Management and Miscellaneous Provisions) Scheme, 1970, to present the results directly to the Board for approval, as the Audit Committee lacked quorum. * The Bank continues to hold a COVID-19 related contingency provision of ₹1200 Crores as of September 30, 2025. * During H1 FY 2025-26, the bank reported 178 fraud cases totaling ₹155.08 Crores, with a loss of ₹133.73 Crores. The bank has maintained 100% provision against this reported loss. * Digital payment frauds amounting to ₹1.04 Crores were reimbursed to customers by debiting the Profit & Loss account, requiring no additional provisioning. * The Reserve Bank of India levied penalties of ₹0.35 Crores on the bank during the half year, which have been fully provided for. * The Provision Coverage Ratio (PCR) as on September 30, 2025, stands at 98.34%.

Filing to action

What to do with a filing like this

Bank of Maharashtra filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Bank of Maharashtra. Read the original for the full detail.

View original filing